161 related articles for article (PubMed ID: 23647505)
41. Lymphoma of the ocular adnexa.
Frimmel SA; Kniestedt C; Töteberg-Harms M; Chaloupka K
Klin Monbl Augenheilkd; 2014 Apr; 231(4):394-404. PubMed ID: 24771177
[TBL] [Abstract][Full Text] [Related]
42. Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children's Oncology Group report.
Goldman S; Smith L; Anderson JR; Perkins S; Harrison L; Geyer MB; Gross TG; Weinstein H; Bergeron S; Shiramizu B; Sanger W; Barth M; Zhi J; Cairo MS
Leukemia; 2013 Apr; 27(5):1174-7. PubMed ID: 22940833
[No Abstract] [Full Text] [Related]
43. Outcome of pediatric non-Hodgkin lymphoma in Central America: A report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA).
Peña-Hernandez A; Ortiz R; Garrido C; Gomez-Garcia W; Fuentes-Alabi S; Martinez R; Metzger ML; Chantada GL; Ribeiro RC
Pediatr Blood Cancer; 2019 May; 66(5):e27621. PubMed ID: 30677231
[TBL] [Abstract][Full Text] [Related]
44. [Comparative effectiveness of treatment of non-Hodgkin's lymphoma in children using protocols BFM NHL-90 and non-programmed courses based on the ACOP regimen].
Lebedev VV; Karachunskiĭ AI; Kryzhanovskiĭ OI; Osokin AG; Rumiantsev AG; Samochatova EV; Belikova LIu; Gorban' ZhI; Kharit MIa; Maschan AA
Gematol Transfuziol; 1994; 39(2):25-9. PubMed ID: 8026684
[TBL] [Abstract][Full Text] [Related]
45. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials.
Seidemann K; Tiemann M; Henze G; Sauerbrey A; Müller S; Reiter A
Med Pediatr Oncol; 1999 Dec; 33(6):536-44. PubMed ID: 10573576
[TBL] [Abstract][Full Text] [Related]
46. In pursuit of a moving target: nanotherapeutics for the treatment of non-Hodgkin B-cell lymphoma.
Knapp CM; Whitehead KA
Expert Opin Drug Deliv; 2014 Dec; 11(12):1923-37. PubMed ID: 25244254
[TBL] [Abstract][Full Text] [Related]
47. Non-Hodgkin lymphoma in pediatric patients with common variable immunodeficiency.
Piquer Gibert M; Alsina L; Giner Muñoz MT; Cruz Martínez O; Ruiz Echevarria K; Dominguez O; Plaza Martín AM; Arostegui JI; de Valles G; Juan Otero M; Martin-Mateos MA
Eur J Pediatr; 2015 Aug; 174(8):1069-76. PubMed ID: 25749928
[TBL] [Abstract][Full Text] [Related]
48. Management of Non-Hodgkin Lymphoma: ICMR Consensus Document.
Thacker N; Bakhshi S; Chinnaswamy G; Vora T; Prasad M; Bansal D; Agarwala S; Kapoor G; Radhakrishnan V; Laskar S; Kaur T; Rath GK; Dhaliwal RS; Arora B
Indian J Pediatr; 2017 May; 84(5):382-392. PubMed ID: 28378140
[TBL] [Abstract][Full Text] [Related]
49. Prognosis and outcome of non-Hodgkin lymphoma in primary Sjögren syndrome.
Voulgarelis M; Ziakas PD; Papageorgiou A; Baimpa E; Tzioufas AG; Moutsopoulos HM
Medicine (Baltimore); 2012 Jan; 91(1):1-9. PubMed ID: 22198497
[TBL] [Abstract][Full Text] [Related]
50. Pilot study of modified LMB-based therapy for children with ataxia-telangiectasia and advanced stage high grade mature B-cell malignancies.
Sandlund JT; Hudson MM; Kennedy W; Onciu M; Kastan MB
Pediatr Blood Cancer; 2014 Feb; 61(2):360-2. PubMed ID: 23900766
[TBL] [Abstract][Full Text] [Related]
51. [Recent advances in pediatric non-Hodgkin lymphoma. Report on a retrospective single-center cohort and review of the literature].
Szegedi I; Gáspár I; Gyurina K; Zele Z; Kiss C
Magy Onkol; 2018 Dec; 62(4):204-213. PubMed ID: 30540862
[TBL] [Abstract][Full Text] [Related]
52. [Sarcoidosis-lymphoma syndrome in a woman with acromegaly].
Siekierska-Hellmann M; Sworczak K; Boj E
Pol Arch Med Wewn; 1995 Dec; 94(6):539-43. PubMed ID: 8618818
[TBL] [Abstract][Full Text] [Related]
53. New therapies in non-Hodgkin lymphoma.
Novelli S; Sierra J; Briones J
Expert Rev Anticancer Ther; 2015 Mar; 15(3):349-59. PubMed ID: 25582186
[TBL] [Abstract][Full Text] [Related]
54. Lymphoreticular disorders in primary immunodeficiencies: new findings based on an up-to-date histologic classification of 35 cases.
Frizzera G; Rosai J; Dehner LP; Spector BD; Kersey JH
Cancer; 1980 Aug; 46(4):692-9. PubMed ID: 6967349
[TBL] [Abstract][Full Text] [Related]
55. Primary immunodeficiency diseases and cancer: the immunodeficiency-cancer registry.
Kersey JH; Spector BD; Good RA
Int J Cancer; 1973 Sep; 12(2):333-47. PubMed ID: 4365092
[No Abstract] [Full Text] [Related]
56. [Large cell anaplastic lymphoma in children--clinical experiences with a newly defined histologic entity].
Heitger A; Gadner H; Bucsky P; Feller AC; Ritter J; Riehm H
Klin Padiatr; 1989; 201(4):237-41. PubMed ID: 2550698
[TBL] [Abstract][Full Text] [Related]
57. Treatment for B-cell-type lymphoma in a girl associated with Bloom's syndrome.
Oto S; Miyamoto S; Kudoh F; Horie H; Kinugawa N; Okimoto Y
Clin Genet; 1992 Jan; 41(1):46-50. PubMed ID: 1633647
[TBL] [Abstract][Full Text] [Related]
58. Low-grade non-Hodgkin's lymphoma after high-grade non-Hodgkin's lymphoma in a child with ataxia telangiectasia.
Overberg-Schmidt U; Wegner RD; Baumgarten E; Günther A; Ebell W; Stein H; Vogel M; Henze G
Cancer; 1994 Mar; 73(5):1522-5. PubMed ID: 8111721
[TBL] [Abstract][Full Text] [Related]
59. Sclerosing cholangitis and intracranial lymphoma in a child with classical Wiskott-Aldrich syndrome.
Vignesh P; Suri D; Rawat A; Lau YL; Bhatia A; Das A; Srinivasan A; Dhandapani S
Pediatr Blood Cancer; 2017 Jan; 64(1):106-109. PubMed ID: 27566838
[TBL] [Abstract][Full Text] [Related]
60. A Modified NHL-BFM-95 Regimen Produces Better Outcome Than HyperCVAD in Adult Patients with T-Lymphoblastic Lymphoma, a Two-Institution Experience.
Li C; Wuxiao ZJ; Chen X; Chen G; Lu Y; Xia Z; Liang Y; Wang H
Cancer Res Treat; 2020 Apr; 52(2):573-585. PubMed ID: 32019289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
